Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL: Atorvastatin vs Rosuvastatin on Platelet Reactivity in CAD
NCT01567774Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Apr 2012
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, rosuvastatin in coronary artery disease (CAD), sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01567774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01567774.